Multimodal treatment of locally advanced esophageal adenocarcinoma: Which regimen should we choose? Outcome analysis of perioperative chemotherapy versus neoadjuvant chemoradiation in 105 patients

Improved Long-Term Survival After Esophagectomy for Esophageal Cancer: Influence of Epidemiologic Shift and Neoadjuvant Therapy

(2013) Frank Makowiec et al.   JOURNAL OF GASTROINTESTINAL SURGERY

Outcomes After Minimally Invasive Esophagectomy

(2012) James D. Luketich et al.   ANNALS OF SURGERY

Preoperative Chemoradiotherapy for Esophageal or Junctional Cancer

(2012) P. van Hagen et al.   NEW ENGLAND JOURNAL OF MEDICINE

Pathological complete remission in patients with oesophagogastric cancer receiving preoperative 5-fluorouracil, oxaliplatin and docetaxel

(2011) Nils Homann et al.   INTERNATIONAL JOURNAL OF CANCER

Perioperative Chemotherapy Compared With Surgery Alone for Resectable Gastroesophageal Adenocarcinoma: An FNCLCC and FFCD Multicenter Phase III Trial

(2011) Marc Ychou et al.   JOURNAL OF CLINICAL ONCOLOGY

S3-Leitlinie „Magenkarzinom” -

(2011) M. Moehler et al.   ZEITSCHRIFT FUR GASTROENTEROLOGIE

Signet Ring Cell Histology is an Independent Predictor of Poor Prognosis in Gastric Adenocarcinoma Regardless of Tumoral Clinical Presentation

(2009) Guillaume Piessen et al.   ANNALS OF SURGERY

Trends in Management and Prognosis for Esophageal Cancer Surgery

(2009) Alberto Ruol   ARCHIVES OF SURGERY

Phase III Comparison of Preoperative Chemotherapy Compared With Chemoradiotherapy in Patients With Locally Advanced Adenocarcinoma of the Esophagogastric Junction

(2009) Michael Stahl et al.   JOURNAL OF CLINICAL ONCOLOGY

Neoadjuvant Chemoradiation Versus Chemotherapy for Patients Undergoing Esophagectomy for Esophageal Cancer

(2008) Theresa D. Luu et al.   ANNALS OF THORACIC SURGERY

Phase III Trial of Trimodality Therapy With Cisplatin, Fluorouracil, Radiotherapy, and Surgery Compared With Surgery Alone for Esophageal Cancer: CALGB 9781

(2008) Joel Tepper et al.   JOURNAL OF CLINICAL ONCOLOGY